Intelligence Β· Patent portfolio
Nektar Therapeutics UK Patents
Full USPTO pharma patent portfolio for Nektar Therapeutics UK β grant dates, expiration, and drug cross-links.
- Patents
- 423
- Expiring β€24m
- 24
Quick answer
Nektar Therapeutics UK has 423 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 24 expire within 24 months β use filters for patent-cliff planning.
-
US 8895553
Oligomer-containing substituted aromatic triazine compounds
granted -
US 8889831
Unit dosage forms of pharmaceutical compositions comprising a polymer-factor VIII polypeptide conjugate
granted -
US 8865149
Polymeric reagents comprising a ketone or a related functional group
granted -
US 8853325
Water-soluble polymer alkanals
granted -
US 8853247
Oligomer-nitroimidazole anti-infective conjugates
granted -
US 8835599
Segmented degradable polymers and conjugates made therefrom
granted -
US 8835556
Hydrolytically stable maleimide-terminated polymers
granted -
US 8828359
Particulate materials
granted -
US 8829043
Oligome-cannabinoid conjugates
granted -
US 8816077
Oligomer-protein tyrosine kinase inhibitor conjugates
granted -
US 8816002
Method involving 1-benzotriazolyl carbonate esters of poly(ethylene glycol)
granted -
US 8815227
Hydroxyapatite-targeting multiarm polymers and conjugates made therefrom
granted -
US 8809489
Methods for preparing polymeric reagents and compositions of polymeric reagents
granted -
US 8809453
Branched polymers
granted -
US 8796248
Oligomer-corticosteroid conjugates
granted -
US 8785661
Oligome-containing pyrrolidine compounds
granted -
US 8784791
Method for preparing water-soluble polymer derivatives bearing an N-succinimidyl ester
granted -
US 8784849
Hydroxyapatite-targeting poly(ethylene glycol) and related polymers
granted -
US 8778898
Oligomer conjugates of heteropentacyclic nucleosides
granted -
US 8771662
Multi-arm polymer prodrugs
granted -
US 8772479
Oligomer-containing substituted aromatic triazine compounds
granted -
US 8765883
Stabilized polymeric thiol reagents
granted -
US 8765111
N-maleimidyl polymer derivatives
granted -
US 8748648
Oligomer-calcium channel blocker conjugates
granted -
US 8728493
Polymer based compositions and conjugates of non-steroidal anti-inflammatory drugs
granted -
US 8722732
Oligomer-calcimimetic conjugates and related compounds
granted -
US 8722032
Thiol-selective water-soluble polymer derivatives
granted -
US 8703115
Methods for preparing conjugates
granted -
US 8685979
Oligomer-diarylpiperazine conjugates
granted -
US 8680263
Carbohydrate-based drug delivery polymers and conjugates thereof
granted -
US 8653286
Intermediates useful in the preparation of maleimide functionalized polymers
granted -
US 8637466
Multi-arm polymeric alkanoate conjugates
granted -
US 8636994
Polymer-based compositions and conjugates of antimicrobial agents
granted -
US 8633277
Methods for forming polymer-drug conjugates
granted -
US 8617530
Polymer conjugates of opioid antagonists
granted -
US 8618259
Polymer-factor VIII conjugate compositions
granted -
US 8604159
Method for preparing functionalized polymers from polymer alcohols
granted -
US 8598364
Oligomer-protease inhibitor conjugates
granted -
US 8586681
Multi-arm block copolymers as drug delivery vehicles
granted -
US 8586711
Polymer-factor IX moiety conjugates
granted -
US 8580919
Polymer conjugates of GLP-1
granted -
US 8575196
Oligomer-opioid agonist conjugates
granted -
US 8575102
Conjugates having a releasable linkage
granted -
US 8569343
Oligomer-opioid agonist conjugates
granted -
US 8569380
Oligomer-tricyclic conjugates
granted -
US 8568705
Method for preparing branched functionalized polymers using branched polyol cores
granted -
US 8562965
Polymer derivatives comprising an acetal or ketal branching point
granted -
US 8563651
Method involving 1-benzotriazolyl carbonate esters of poly(ethylene glycol)
granted
Frequently asked questions
How many patents does Nektar Therapeutics UK have?
423 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Nektar Therapeutics UK patents expire?
24 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory